1. Home
  2. WLY vs CERT Comparison

WLY vs CERT Comparison

Compare WLY & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLY
  • CERT
  • Stock Information
  • Founded
  • WLY 1807
  • CERT 2008
  • Country
  • WLY United States
  • CERT United States
  • Employees
  • WLY N/A
  • CERT N/A
  • Industry
  • WLY Books
  • CERT Retail: Computer Software & Peripheral Equipment
  • Sector
  • WLY Consumer Discretionary
  • CERT Technology
  • Exchange
  • WLY Nasdaq
  • CERT Nasdaq
  • Market Cap
  • WLY 2.2B
  • CERT 2.3B
  • IPO Year
  • WLY N/A
  • CERT 2020
  • Fundamental
  • Price
  • WLY $44.43
  • CERT $9.91
  • Analyst Decision
  • WLY
  • CERT Buy
  • Analyst Count
  • WLY 0
  • CERT 6
  • Target Price
  • WLY N/A
  • CERT $15.80
  • AVG Volume (30 Days)
  • WLY 621.7K
  • CERT 1.2M
  • Earning Date
  • WLY 03-06-2025
  • CERT 05-06-2025
  • Dividend Yield
  • WLY 3.18%
  • CERT N/A
  • EPS Growth
  • WLY N/A
  • CERT N/A
  • EPS
  • WLY 0.75
  • CERT N/A
  • Revenue
  • WLY $1,703,491,000.00
  • CERT $385,148,000.00
  • Revenue This Year
  • WLY N/A
  • CERT $11.44
  • Revenue Next Year
  • WLY $1.13
  • CERT $8.90
  • P/E Ratio
  • WLY $59.11
  • CERT N/A
  • Revenue Growth
  • WLY N/A
  • CERT 8.70
  • 52 Week Low
  • WLY $34.85
  • CERT $9.41
  • 52 Week High
  • WLY $53.96
  • CERT $19.18
  • Technical
  • Relative Strength Index (RSI)
  • WLY 56.08
  • CERT 26.70
  • Support Level
  • WLY $44.19
  • CERT $10.21
  • Resistance Level
  • WLY $45.08
  • CERT $11.12
  • Average True Range (ATR)
  • WLY 1.05
  • CERT 0.49
  • MACD
  • WLY -0.02
  • CERT -0.05
  • Stochastic Oscillator
  • WLY 31.25
  • CERT 14.20

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: